Related references
Note: Only part of the references are listed.HapMap scanning of novel human minor histocompatibility antigens
Michi Kamei et al.
BLOOD (2009)
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
Biagio De Angelis et al.
BLOOD (2009)
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells
Kellie V. Rosinski et al.
BLOOD (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations
Eric Spierings et al.
PLOS GENETICS (2007)
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
JP Huang et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
DJ Powell et al.
BLOOD (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Minors come of age: Minor histocompatibility antigens and graft-versus-host disease
NJ Chao
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
JHF Falkenburg et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
SSB Randolph et al.
BLOOD (2004)
Molecules and mechanisms of the graft-versus-leukaemia effect
M Bleakley et al.
NATURE REVIEWS CANCER (2004)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens
AM Dickinson et al.
NATURE MEDICINE (2002)
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
JE Levine et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
P Fontaine et al.
NATURE MEDICINE (2001)
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2001)
The human UTY gene encodes a novel HLA-BS-restricted H-Y antigen
EH Warren et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
